HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olanzapine augmentation of fluoxetine in body dysmorphic disorder.

AuthorsKatharine A Phillips
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 162 Issue 5 Pg. 1022-3 (May 2005) ISSN: 0002-953X [Print] United States
PMID15863817 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antipsychotic Agents
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Benzodiazepines
  • Olanzapine
Topics
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • Benzodiazepines (therapeutic use)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Fluoxetine (therapeutic use)
  • Humans
  • Male
  • Olanzapine
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Somatoform Disorders (drug therapy, psychology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: